Yoon Hee Choi Selected Research

Yoon Hee Choi Research Topics

Disease

8	Neoplasms (Cancer) 04/2024 - 06/2010
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 04/2010
4	Disease Progression 04/2019 - 11/2012
3	Adenoid Cystic Carcinoma (Cylindroma) 04/2024 - 10/2021
3	Out-of-Hospital Cardiac Arrest 12/2020 - 01/2020
3	Heart Arrest (Cardiac Arrest) 06/2020 - 01/2019
3	Stomach Neoplasms (Stomach Cancer) 10/2013 - 02/2012
2	Pain (Aches) 03/2024 - 01/2023
2	Urinary Tract Infections (Urinary Tract Infection) 09/2023 - 02/2023
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 01/2020
2	Poisoning 01/2020 - 07/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 08/2007
2	Adenocarcinoma 01/2016 - 10/2013
2	Colorectal Neoplasms (Colorectal Cancer) 01/2012 - 10/2011
1	Calculi (Calculus) 03/2024
1	Ureteral Calculi 03/2024
1	Hemorrhage 08/2023
1	Wounds and Injuries (Trauma) 02/2023
1	Foreign Bodies (Foreign Body) 01/2023
1	Deglutition Disorders (Dysphagia) 01/2023
1	Fatigue 10/2021
1	Stomatitis 10/2021
1	Lung Neoplasms (Lung Cancer) 08/2021
1	Post-Cardiac Arrest Syndrome 12/2020
1	Hyperglycemia 01/2019
1	Rhabdomyolysis 07/2018
1	Graves Ophthalmopathy 11/2017
1	Muscle Weakness 06/2017
1	Hematoma 10/2014
1	Myocardial Infarction 10/2014
1	Obesity 07/2014
1	Neoplasm Metastasis (Metastasis) 03/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2014
1	Neutropenia 10/2013
1	False Aneurysm (Pseudoaneurysm) 01/2012
1	Postpartum Hemorrhage 01/2012
1	Rupture 01/2012

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 04/2019 - 02/2012
3	Pemetrexed (MTA)FDA Link 04/2019 - 04/2010
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016 - 11/2012
2	Tyrosine Kinase InhibitorsIBA 04/2024 - 04/2019
2	Axitinib (AG 013736)IBA 12/2023 - 10/2021
2	PlatinumIBA 02/2023 - 08/2021
2	osimertinibIBA 07/2022 - 10/2020
2	ErbB Receptors (EGF Receptor)IBA 10/2020 - 04/2019
2	Fluorouracil (Carac)FDA LinkGeneric 01/2016 - 10/2011
2	Leucovorin (Folinic Acid)FDA Link 01/2016 - 10/2011
2	Docetaxel (Taxotere)FDA Link 10/2013 - 11/2012
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2012 - 10/2011
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2024
1	Analgesics (Analgesic Drugs)IBA 03/2024
1	Biomarkers (Surrogate Marker)IBA 12/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 08/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2023
1	palbociclibIBA 02/2023
1	C-Reactive ProteinIBA 01/2023
1	SodiumIBA 01/2023
1	AfatinibIBA 07/2022
1	pembrolizumabIBA 08/2021
1	AntibodiesIBA 08/2021
1	Immune Checkpoint InhibitorsIBA 08/2021
1	NivolumabIBA 08/2021
1	LigandsIBA 08/2021
1	ElementsIBA 12/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	Lipocalin-2IBA 01/2020
1	Pharmaceutical Sleep AidsIBA 01/2020
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2019
1	CarbohydratesIBA 01/2019
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2019
1	Acarbose FDA LinkGeneric 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	DoxylamineIBA 07/2018
1	Troleandomycin (TAO)FDA Link 11/2017
1	Heparin (Liquaemin)FDA LinkGeneric 10/2014
1	CarbamatesIBA 07/2014
1	OrganophosphatesIBA 07/2014
1	Messenger RNA (mRNA)IBA 03/2014
1	dimethyl sulfone (methylsulfonylmethane)IBA 03/2014
1	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 03/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2014
1	titanium silicide (TS-1)IBA 10/2013
1	Capecitabine (Xeloda)FDA Link 02/2012
1	Sorafenib (BAY 43-9006)FDA Link 02/2012
1	ParaffinIBA 12/2010

Therapy/Procedure

8	Therapeutics 04/2024 - 08/2007
5	Drug Therapy (Chemotherapy) 07/2022 - 06/2010
5	Induced Hypothermia 12/2020 - 01/2019
2	Length of Stay 03/2024 - 07/2018
2	Resuscitation 02/2023 - 01/2012
2	Combination Drug Therapy (Combination Chemotherapy) 02/2023 - 11/2012
2	Adjuvant Chemotherapy 10/2013 - 11/2012
1	Pain Management 03/2024
1	Long-Term Care 09/2023
1	Critical Care (Surgical Intensive Care) 12/2020
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020
1	Surgical Decompression 10/2014
1	Oral Administration 03/2014
1	Neoadjuvant Therapy 10/2013
1	Cesarean Section (Caesarean Section) 01/2012